Discover why operating cash flow is a more reliable metric than net income for assessing financial health and avoiding accounting manipulation risks.

Analyst Insight: Many biotech firms struggle to manage the order-to-cash (O2C) cycle effectively because large contract manufacturers (CMOs) often handle physical shipping, while the firm retains ...

Learn how to tell if your business could be facing a cash crunch—and what to do about it Written By Written by Staff Senior Editor, Buy Side Miranda Marquit is a staff senior personal finance editor ...

Not long after Nate Scheelhaase arrived at Iowa State as a running backs coach in 2018, he was in the office of athletic director Jamie Pollard a few times a month. The program thought it best to ...

In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved the first at-home brain-stimulation device to treat moderate to severe major ...

Looking to 2026, Bitcoin (BTC) forecasts clash with historical chart patterns and evolving market realities, as traditional finance plays a bigger role in the cryptocurrency space. Standard Chartered ...

Takeaways from an eventful 2025 election cycle. By Caroline Soler, Christine Zhang and Alex Lemonides Is there such a thing as an “off year” for U.S. elections? The elections in 2025 were not nearly ...

In this post, we will show you how to create real-time interactive flowcharts for your code using VS Code CodeVisualizer. CodeVisualizer is a free, open-source Visual Studio Code extension that ...

A new KFF analysis reveals that retrospective chart reviews are a primary driver of risk-adjusted payments for Medicare Advantage insurers, often adding diagnoses, and revenue, without accompanying ...

The FDA has approved its first at-home, nondrug therapy for depression, with a wearable brain stimulation headset developed by Flow Neuroscience. The agency issued a green light that covers the device ...

Newmont delivered $1.6B in Q3 FCF, its fourth consecutive quarter above $1B, confirming exceptional cash generation and balance sheet strength in the middle of this new gold cycle. The company enters ...